Advertisement

Clinical and Immunological Features of HCV/HIV Co-infected Patients with Mixed Cryoglobulinemia

  • David Saadoun
  • Patrice P. Cacoub
Chapter

Abstract

Mixed cryoglobulinemia (MC) is a systemic vasculitis leading to clinical manifestations ranging from MC syndrome (purpura, arthralgia, asthenia) to more serious lesions with neurologic and renal involvement. Hepatitis C virus (HCV) infection is associated with most cases of MC. While many other viral infections have been reported to cause MC vasculitis most of these reports are anecdotal. Cryoglobulins are detected in 17–26% of human immunodeficiency virus (HIV)-infected patients but are rarely associated with MC vasculitis. Several reports have found a higher cryoglobulin prevalence in HIV/HCV co-infected patients than in HCV patients. Case reports of MC vasculitis in HIV/HCV co-infected patients are extremely rare. The role of cellular immunity in the pathogenesis of MC vasculitis in HIV/HCV co-infected patients is supported by an initial CD4 cell counts >250/mm3 in all cases. Compared with HCV-MC patients, HIV/HCV-MC co-infected patients were younger, more frequently of male gender, and intravenous drug users. They had higher HCV RNA level, liver necroinflammation, and gammaglobulin levels, and a lower cryoglobulin level. However, the clinical manifestations of MC vasculitis in co-infected patients did not differ significantly from those in HCV mono-infected patients. A beneficial effect of anti-HCV therapy was evidenced in HIV/HCV co-infected patients with MC vasculitis.

Keywords

Human Immunodeficiency Virus Mixed Cryoglobulinemia Human Immunodeficiency Virus Infected Patient Mixed Cryoglobulinemia Patient Mixed Cryoglobulinemia Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Gorevic PD, Kassab HJ, Levo Y et al (1980) Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69:287–308PubMedCrossRefGoogle Scholar
  2. 2.
    Agnello V, Chung RT, Kaplan LM (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490–1495PubMedCrossRefGoogle Scholar
  3. 3.
    Bonnet F, Pineau JJ, Taupin JL et al (2003) Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients. J Rheumatol 30:2005–2010PubMedGoogle Scholar
  4. 4.
    Dimitrakopoulos AN, Kordossis T, Hatzakis A, Mout­sopoulos HM (1999) Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med 130:226–230PubMedCrossRefGoogle Scholar
  5. 5.
    Stricker RB, Sanders KA, Owen WF et al (1992) Monon­euritis multiplex associated with cryoglobulinemia in HIV infection. Neurology 42:2103–2105PubMedCrossRefGoogle Scholar
  6. 6.
    Castillo JR, Kirchner E, Farver C, Calabrese LH (2005) Cryoglobulinemic vasculitis and lymphocytic interstitial pneumonitis in a person with HIV infection. AIDS Read 15:252–255PubMedGoogle Scholar
  7. 7.
    Sulkowski MS, Mast EE, Seeff LB, Thomas DL (2000) Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 30(Suppl 1):S77–S84PubMedCrossRefGoogle Scholar
  8. 8.
    Cacoub P, Renou C, Rosenthal E et al (2000) Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore) 79:47–56CrossRefGoogle Scholar
  9. 9.
    Cohen P, Roulot D, Ferriere F et al (1997) Prevalence of cryoglobulins and hepatitis C virus infection in HIV-infected patients. Clin Exp Rheumatol 15:523–527PubMedGoogle Scholar
  10. 10.
    Monsuez JJ, Vittecoq D, Musset L et al (1998) Arthralgias and cryoglobulinemia during protease inhibitor therapy in a patient infected with human immunodeficiency virus and hepatitis C virus. Arthritis Rheum 41:740–743PubMedCrossRefGoogle Scholar
  11. 11.
    Antinori S, Galimberti L, Rusconi S et al (1995) Disap­pearance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection. Clin Exp Rheumatol 13(Suppl 13):S157–S159PubMedGoogle Scholar
  12. 12.
    Calabrese LH (2004) Infection with the human immunodeficiency virus type 1 and vascular inflammatory disease. Clin Exp Rheumatol 22:S87–S93PubMedGoogle Scholar
  13. 13.
    Gherardi R, Belec L, Mhiri C et al (1993) The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis Rheum 36:1164–1174PubMedCrossRefGoogle Scholar
  14. 14.
    Le Lostec Z, Fegueux S, Vitale C et al (1994) Peripheral neuropathy associated with cryoglobulinaemia but not related to hepatitis C virus in an HIV-infected patient. AIDS 8:1351–1352PubMedCrossRefGoogle Scholar
  15. 15.
    Gisselbrecht M, Cohen P, Lortholary O et al (1998) Human immunodeficiency virus-related vasculitis. Clinical presentation of and therapeutic approach to eight cases. Ann Med Interne (Paris) 149:398–405Google Scholar
  16. 16.
    Aaron L, Lebray P, Alyanakian MA et al (2005) Prevalence of mixed cryoglobulins in relation to CD4 cell count among patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 40:306–308PubMedCrossRefGoogle Scholar
  17. 17.
    Saadoun D, Aaron L, Resche-Rigon M et al (2006) Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus. AIDS 20:871–877PubMedCrossRefGoogle Scholar
  18. 18.
    Mackay F, Ambrose C (2003) The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev 14:311–324PubMedCrossRefGoogle Scholar
  19. 19.
    Boyer O, Saadoun D, Abriol J et al (2004) CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103:3428–3430PubMedCrossRefGoogle Scholar
  20. 20.
    Bonetti B, Invernizzi F, Rizzuto N et al (1997) T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy. J Neuroimmunol 73:145–154PubMedCrossRefGoogle Scholar
  21. 21.
    Cacoub P, Lidove O, Maisonobe T et al (2002) Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46:3317–3326PubMedCrossRefGoogle Scholar
  22. 22.
    Cacoub P, Saadoun D, Limal N et al (2005) PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 52:911–915PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  1. 1.Department of Internal MedicineHôpital La Pitié-SalpêtrièreParisFrance
  2. 2.UMR 7211 (UPMC/CNRS), U 959 (INSERM)Université Pierre Marie CurieParisFrance

Personalised recommendations